Search Results 1891-1900 of 16169 for Epilepsy (Partial Onset)

  1. Tinnitus - Doctors and departments - Mayo Clinic

    Tinnitus can be caused by many health conditions. As such, the symptoms and treatment options vary by person. Get the facts in this comprehensive overview.

  2. A Study to Assess Cardiovascular Phenotype Driven Genomic Research - Mayo Clinic

    Patient with early onset coronary heart disease (CHD)/lipid disorders/other cardiovascular disease (CVD) with suspected/known genetic etiology referred from ...

  3. A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgitation Subjects Receiving the MitraClip® Device - Mayo Clinic

    Subject must not have any disabilities that preclude reliable data collection from the Actiwatch, e.g., epilepsy with uncontrolled recurring episodes ...

  4. Trigeminal neuralgia - Doctors and departments - Mayo Clinic

    Zimmerman, M.D.. Neurosurgeon. Phoenix, AZ. Areas of focus: Epilepsy surgery, Brain tumor surgery, Carotid endarterectomy, Trigeminal neuralgia surgery ...

  5. Apremilast (oral route) - Mayo Clinic

    Apremilast is used to treat active psoriatic arthritis and oral ulcers caused by Behçet's disease. It is also used to treat plaque psoriasis in patients who may ...

  6. Living With Cancer: Opioids and cancer pain - Mayo Clinic News Network

    Symptoms may include headache, nausea, vomiting, unusual tiredness, dizziness, double vision, unsteady walk or seizures. Learn more about the diagnosis and ...

  7. Publications - Clement J. Michet, Jr., M.D. - Mayo Clinic

    The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011 Mar; 63 (3):633-9. View ...

  8. PF-04449913 Single-Agent In Patients with Myelofibrosis Previously Treated with a Janus Kinase Inhibitor - Mayo Clinic

    Previous treatment with 1 or more JAK inhibitors (licensed or experimental) for a minimum duration of at least 4 weeks and failure to achieve or sustain ...

  9. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

    A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with ...

  10. Bictegravir, emtricitabine, and tenofovir alafenamide (oral route) - Mayo Clinic

    HIV is the virus that causes acquired immune deficiency syndrome (AIDS). This medicine is usually given to patients who have yet to receive any medicine for ...